Jubilant Pharma-Consolidation breakout can give good returns

Actualizado
Jubilant pharmova has been trading in a big range since last few years.
Stock has managed to close above the resistance and has also retested the breakout.
Stock has potential to fly from this levels.

Keep stock in watchlist. A nifty500 stock and hence can be relatively safer option.
Not a recommendation.
Operación activa
chartanalysisdarvasboxjubilantpharmanifty500PHARMARectanglestrongbreakoutSupply and Demandweeklybreakout

También en:

Exención de responsabilidad